Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil.
作者信息
Fagundes Evandro M, Neto Naira N, Caldas Lorena M, Aragão Jordana R, Gloria Ana Beatriz F, Leite Leonardo G, Bastos Paula, Fernandes Carolina M, Chalup Mariana, Arcuri Rosa, Fagundes Olivia G
机构信息
Oncoclínicas Belo Horizonte, Rua dos Otoni 881, 15o andar, Belo Horizonte, Minas Gerais, 30150-270, Brazil.
Centro de Oncologia Dr, Oswaldo Leite, Aracaju, Brazil.
出版信息
Ann Hematol. 2022 Apr;101(4):923-925. doi: 10.1007/s00277-021-04659-w. Epub 2021 Sep 17.
Abstract
摘要
相似文献
1
Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil.成人急性髓系白血病患者中由新型冠状病毒肺炎导致的死亡率：一项针对巴西血液学家的调查
Ann Hematol. 2022 Apr;101(4):923-925. doi: 10.1007/s00277-021-04659-w. Epub 2021 Sep 17.
2
COVID-19 after hematopoietic stem cell transplantation: report of two children.造血干细胞移植后发生的新型冠状病毒肺炎：两名儿童的病例报告
Bone Marrow Transplant. 2021 Mar;56(3):713-715. doi: 10.1038/s41409-020-01041-8. Epub 2020 Sep 16.
3
Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.巴西圣保罗市受影响最严重地区 SARS-CoV-2 初始血清流行率评估。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101604. doi: 10.1016/j.bjid.2021.101604. Epub 2021 Aug 10.
4
Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France.法国成年急性白血病患者感染新型冠状病毒肺炎的特征及临床结局
Leuk Res. 2022 Sep;120:106901. doi: 10.1016/j.leukres.2022.106901. Epub 2022 Jun 20.
5
Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.伊朗 COVID-19 合并急性髓系白血病患者的致命性侵袭性肺曲霉病。
Mycopathologia. 2020 Dec;185(6):1077-1084. doi: 10.1007/s11046-020-00493-2. Epub 2020 Oct 3.
6
COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey.慢性期慢性髓性白血病患者中的新型冠状病毒肺炎：来自土耳其的单中心调查
Turk J Haematol. 2021 Feb 25;38(1):79-81. doi: 10.4274/tjh.galenos.2020.2020.0472. Epub 2020 Sep 23.
7
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
8
A forensic analysis of SARS-CoV-2 cases and COVID-19 mortality misreporting in the Brazilian population.巴西人群中 SARS-CoV-2 病例和 COVID-19 死亡率漏报的法医分析。
Public Health. 2021 Jul;196:114-116. doi: 10.1016/j.puhe.2021.05.010. Epub 2021 May 19.
9
SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.SARS-CoV-2 再感染：巴西东南部两例报告。
Rev Inst Med Trop Sao Paulo. 2021 Jun 18;63:e50. doi: 10.1590/S1678-9946202163050. eCollection 2021.
10
Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.新型冠状病毒肺炎感染后急性白血病患者的异基因干细胞移植
Bone Marrow Transplant. 2021 Jun;56(6):1478-1481. doi: 10.1038/s41409-021-01225-w. Epub 2021 Feb 9.
引用本文的文献
1
Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/Idarubicin.一名患有活动性新冠肺炎感染和难治性急性髓系白血病的患者，在接受阿糖胞苷/伊达比星成功再诱导治疗后病毒清除与中性粒细胞恢复情况
Case Rep Oncol. 2022 Aug 3;15(2):705-712. doi: 10.1159/000525766. eCollection 2022 May-Aug.
2
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).成人急性髓系白血病患者中的 COVID-19：来自欧洲血液学协会调查（EPICOVIDEHA）的长期随访研究。
Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.
3
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response.COVID-19 与血液系统恶性肿瘤患者：临床表现、持续性和免疫反应。
Acta Haematol. 2022;145(3):297-309. doi: 10.1159/000523872. Epub 2022 Mar 2.
4
Impact of COVID-19 in patients with multiple myeloma based on a global data network.基于全球数据网络的 COVID-19 对多发性骨髓瘤患者的影响。
Blood Cancer J. 2021 Dec 10;11(12):198. doi: 10.1038/s41408-021-00588-z.
本文引用的文献
1
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.血液系统恶性肿瘤患者对2019冠状病毒病信使核糖核酸疫苗的反应欠佳：在后口罩时代需要保持警惕
Open Forum Infect Dis. 2021 Jun 30;8(7):ofab353. doi: 10.1093/ofid/ofab353. eCollection 2021 Jul.
2
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
3
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.2019冠状病毒病（COVID-19）时代成人急性白血病和髓系肿瘤患者管理的特殊考量：国际专家小组的建议
Lancet Haematol. 2020 Aug;7(8):e601-e612. doi: 10.1016/S2352-3026(20)30205-2. Epub 2020 Jun 18.
4
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.新型冠状病毒肺炎疫情期间急性白血病患者的管理：欧洲血液与骨髓移植学会急性白血病工作组实用指南
Bone Marrow Transplant. 2021 Mar;56(3):532-535. doi: 10.1038/s41409-020-0970-x. Epub 2020 Jun 11.
5
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?从诊断到治疗的时间是否会影响新诊断为急性髓系白血病患者的预后？
Blood. 2020 Aug 13;136(7):823-830. doi: 10.1182/blood.2019004583.
6
Treating Leukemia in the Time of COVID-19.在 COVID-19 期间治疗白血病。
Acta Haematol. 2021;144(2):132-145. doi: 10.1159/000508199. Epub 2020 May 11.
7
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件